
Join to view full profile
1 Hoag DriveBuilding 41Newport Beach, CA 92663
Phone+1 949-764-4060
Dr. Benjamin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2019 - 2022
University of California Davis HealthResidency, Internal Medicine, 2016 - 2019
Tulane University School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Genitourinary Cancers Symposium Merit Award Conquer Cancer, the ASCO Foundation, 2022
- Outstanding Fellow/Resident Research Award – Clinical/Translational Research UCI School of Medicine, 2022
Clinical Trials
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2025 Jan 23
- Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) Start of enrollment: 2022 Sep 15
- A Phase 1 Study of BHV-1530 in Advanced Solid Tumors Start of enrollment: 2025 Mar 20
Publications & Presentations
PubMed
- Why counting women is not enough: from inclusion to equity in oncology trials.David J Benjamin, Sophie Zaaijer, Shera Feinstein, Arash Rezazadeh Kalebasty
Nature Reviews. Urology. 2026-06-16 - Quality of life with EV-302 in advanced urothelial carcinoma: lessons and implications.David J Benjamin, Arash Rezazadeh Kalebasty
Translational Cancer Research. 2026-05-30 - Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV).Morgann Madill, Udhayvir Grewal, Harris Krause, Andrew Elliott, Marya Wahidi
Infectious Agents and Cancer. 2026-05-02
Abstracts/Posters
- Ivermectin in Cancer, 2025: Internet Trends, Scientific Data, Ongoing Trials, and News CoverageDavid J. Benjamin, Arash Rezazadeh, ESMO Congress 2025, Berlin, Germany, 10/19/2025
- State of the genitourinary medical oncology workforce in the United States, 2024David Joseph Benjamin, Arash Rezazadeh, ASCO Genitourinary Cancers Symposium, San Francisco, CA, 2/15/2025
- Characterization of genitourinary drug approvals by the FDA, 2020-2024David Joseph Benjamin, Arash Rezazadeh, ASCO Genitourinary Cancers Symposium, San Francisco, CA, 2/14/2025
Lectures
- The Global Medical Oncology Workforce, 2025: Disparities in Access to CareESMO Congress 2025, Berlin, Germany - 10/18/2025
- Navigating la/mUC Treatment Options: Right Treatment for the Right PatientAVENUES Medical Meeting, Lisbon, Portugal - 5/10/2025
- Retrospective Analysis of Treatment Initiation and Treatment Delay in Metastatic Renal Cell CarcinomaDAVA Oncology 7th Annual Summit on Genitourinary Malignancies. Colorado Springs, CO - 11/24/2024
Authored Content
- I Watched 100 Movies About Cancer. Here's What They Get WrongMay 2024
Press Mentions
Ivermectin and Cancer: Navigating Patient Curiosity in Oncology NursingJuly 27th, 2026
As “The Pitt” Puts Physicians in the Limelight, Hollywood Is Still Missing the Mark on Oncology RealityJanuary 22nd, 2026
Disparities in Global Oncology Workforce Have Consequences for Cancer CareNovember 17th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









